ArticleToxins2021

Engineering of Cytolethal Distending Toxin B by Its Reducing Immunogenicity and Maintaining Stability as a New Drug Candidate for Tumor Therapy; an In Silico Study.

Maryam Keshtvarz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.